drugset
drugset / Trial / NCT01034748

A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male Volunteers

NCT01034748 ↗

Phase 1 Completed 6 enrolled Pfizer Syneos Health · collab
Non-randomizedSingle-groupOpen-labelBasic science

Summary

This is single dose study of radiolabeled \[14C\]PF-00299804 in healthy male volunteers to study the absorption, distribution, metabolism and elimination of PF-00299804.

Timeline

Start
2010-01
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject DACOMITINIB ANHYDROUS Small molecule 45 mg Oral

Indications

non-small cell lung carcinoma